From: Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients
Observed number | Proportion [%] | LL 95% | UL 95% | Proportion [%] in Sweden 1970 | Proportion [%] in Sweden 2010 | Reference outside CI | |
---|---|---|---|---|---|---|---|
Uterus | 8 | 21.05 | 7.89 | 34.21 | 5.84 | 5.15 | CI above reference |
Colon/rectum | 5 | 13.16 | 2.63 | 23.68 | 11.61 | 10.3 | No |
Breast | 5 | 13.16 | 2.63 | 23.68 | 23.53 | 32.07 | No |
Stomach | 3 | 7.89 | 0 | 18.42 | 5.14 | 1.15 | No |
Lung and airways | 3 | 7.89 | 0 | 18.42 | 2.73 | 6.37 | No |
Ovary and Fallopian tube | 3 | 7.89 | 0 | 18.42 | 7.14 | 3.01 | No |
Unspecified location | 3 | 7.89 | 0 | 18.42 | 3.36 | 2.49 | No |
Liver and biliary system | 2 | 5.26 | 0 | 13.16 | 3.35 | 1.46 | No |
Cervix | 2 | 5.26 | 0 | 13.16 | 5.92 | 2.35 | No |
Thyroid | 2 | 5.26 | 0 | 13.16 | 1.7 | 1.86 | No |
Malignant melanoma | 1 | 2.63 | 0 | 7.89 | 2.72 | 6.08 | No |
Blood and lymphatic tissue | 1 | 2.63 | 0 | 7.89 | 7.34 | 7.19 | No |